Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (33)
Peter R. Foster. (2013)
Plasma products and prion removal: “
Is you is or is you ain't …?”
. Transfusion 53:9, pages 1873-1875.
Crossref
Crossref
P. L. Roberts, J. Dalton, D. Evans, P. Harrison, Z. Li, K. Ternouth, V. Thirunavukkarasu, M. Bulmer, S. Fernando & N. McLeod. (2012) Removal of TSE agent from plasma products manufactured in the United Kingdom. Vox Sanguinis 104:4, pages 299-308.
Crossref
Crossref
Marc L. Turner. 2013. Practical Transfusion Medicine. Practical Transfusion Medicine
152
160
.
Myrto-Panagiota Zacharof & Robert W. Lovitt. (2013) Low molecular weight liquid media development for Lactobacilli producing bacteriocins. Journal of Chemical Technology & Biotechnology 88:1, pages 72-80.
Crossref
Crossref
Pavlina Sobrova, Marketa Ryvolova, David Hynek, Vojtech Adam, Jaromir Hubalek & Rene Kizek. (2012) Electrochemical Behaviour of Native and Denatured β-Sheet Breaker Prion Protein. International Journal of Electrochemical Science 7:2, pages 928-942.
Crossref
Crossref
John J. Wille, Jeremy J. Burdge & Mark R. Pitttelkow. (2011) Rapid healing of chronic venous stasis leg ulcers treated by the application of a novel serum‐free cultured autologous epidermis. Wound Repair and Regeneration 19:4, pages 464-474.
Crossref
Crossref
J. Coste, C. Prowse, R. Eglin & C. Fang. (2009) A report on transmissible spongiform encephalopathies and transfusion safety. Vox Sanguinis 96:4, pages 284-291.
Crossref
Crossref
Peter R. Foster & Carol Bienek. 2010. Transfusion Microbiology. Transfusion Microbiology
259
304
.
Marc L. Turner, Patricia E. Hewitt, Moira Bruce, James W. Ironside, David J. Anstee & Gary Mallinson. 2010. Transfusion Microbiology. Transfusion Microbiology
141
152
.
Hsiu-Hao Chang, Yung-Li Yang, Mei-Hua Hung, Woei Tsay & Ming-Ching Shen. (2007) Pharmacokinetic Study of Recombinant Human Factor IX in Previously Treated Patients with Hemophilia B in Taiwan. Journal of the Formosan Medical Association 106:4, pages 281-287.
Crossref
Crossref
Marc L. Turner. 2005. Practical Transfusion Medicine. Practical Transfusion Medicine
229
237
.
Marie Reilly, Agus Salim, Emer Lawlor, Owen Smith, Ian Temperley & Yudi Pawitan. (2004) Modelling infectious disease transmission with complex exposure pattern and sparse outcome data. Statistics in Medicine 23:19, pages 3013-3032.
Crossref
Crossref
Peter R. Foster. 2001. Kirk-Othmer Encyclopedia of Chemical Technology. Kirk-Othmer Encyclopedia of Chemical Technology.
Edward L. Murphy, J. David Connor, Patrick McEvoy, Nora Hirschler, Michael P. Busch, Paula Roberts, Kim-Ank Nguyen & Pascale Reich. (2004) Estimating blood donor loss due to the variant CJD travel deferral. Transfusion 44:5, pages 645-650.
Crossref
Crossref
L Gregori, J.-A Maring, C MacAuley, B Dunston, M Rentsch, C Kempf & R.G Rohwer. (2004) Partitioning of TSE infectivity during ethanol fractionation of human plasma. Biologicals 32:1, pages 1-10.
Crossref
Crossref
P. R. Foster, B. D. Griffin, C. Bienek, R. V. McIntosh, I. R. MacGregor, R. A. Somerville, P. J. Steele & H. E. Reichl. (2004) Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII. Vox Sanguinis 86:2, pages 92-99.
Crossref
Crossref
H. E. Karges. 2004. Transfusionsmedizin. Transfusionsmedizin
299
325
.
David A. Sacks. 2004. Critical Care Obstetrics. Critical Care Obstetrics
162
183
.
Barbara Glock, Maya Winter, Simone O. Rennhofer, Elisabeth Brunhölzl, Doris Tröscher, Rosemarie B.K. Reisacher & Wolfgang R. Mayr. (2003) Transcript level of erythroid differentiation-related factor, a candidate surrogate marker for transmissible spongiform encephalopathy diseases in blood, shows a broad range of variation in healthy individuals. Transfusion 43:12, pages 1706-1710.
Crossref
Crossref
Simon A Brown, Louis M Aledort & Christine A Lee. (2003) Molecular challenges and viral diseases. Haemophilia 9:6, pages 727-737.
Crossref
Crossref
R. W. Van Holten & S. M. Autenrieth. (2003) Evaluation of depth filtration to remove prion challenge from an immune globulin preparation. Vox Sanguinis 85:1, pages 20-24.
Crossref
Crossref
Donald J. AbrahamBarbara Campanini, Stefano Bruno, Samanta Raboni & Andrea Mozzarelli. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
385
441
.
CV Prowse MA & IR MacGregor. (2002) Mad Cows and Englishmen: An Update on Blood and vCJD. Vox Sanguinis 83, pages 341-349.
Crossref
Crossref
Robert W. Van Holten, Stephen Autenrieth, Jeri Ann Boose, W.‐T. Hsieh & Sherri Dolan. (2002) Removal of prion challenge from an immune globulin preparation by use of a size‐exclusion filter. Transfusion 42:8, pages 999-1004.
Crossref
Crossref
H. E. Reichl, P. R. Foster, A. G. Welch, Q. Li, I. R. MacGregor, R. A. Somerville, K. Fernie, P. J. Steele & D. M. Taylor. (2002) Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin. Vox Sanguinis 83:2, pages 137-145.
Crossref
Crossref
Christine L Whitworth. (2002) Variant Creutzfeldt-Jakob Disease—A Problem for General Dental Practitioners?. Primary Dental Care os9:3, pages 95-99.
Crossref
Crossref
Adam Balen. (2002) Bye-bye urinary gonadotrophins?. Human Reproduction 17:7, pages 1676-1680.
Crossref
Crossref
Omar Lupi. (2002) Prions in dermatology. Journal of the American Academy of Dermatology 46:5, pages 790-793.
Crossref
Crossref
Kang Cai, Jeanette L.C. Miller, Christopher J. Stenland, Kevin J. Gilligan, Randal C. Hartwell, Jarrett C. Terry, Rosemary B. Evans-Storms, Richard Rubenstein, Stephen R. PettewayJr.Jr. & Douglas C. Lee. (2002) Solvent-dependent precipitation of prion protein. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1597:1, pages 28-35.
Crossref
Crossref
Nils Strandberg Pedersen & Else Smith. (2002) Prion diseases: Epidemiology in man. APMIS 110:1, pages 14-22.
Crossref
Crossref
Marc L. Turner. (2001) Variant Creutzfeldt-Jakob disease and blood transfusion. Current Opinion in Hematology 8:6, pages 372-379.
Crossref
Crossref
Naomi V. Dahl. (2001) Alternative Medicine and Nephrology Series Editor: Naomi V. Dahl: Herbs and Supplements in Dialysis Patients: Panacea or Poison?. Seminars in Dialysis 14:3, pages 186-192.
Crossref
Crossref
P. R. Foster. 2001. Transfusion Medicine: Quo Vadis? What Has Been Achieved, What Is to Be Expected. Transfusion Medicine: Quo Vadis? What Has Been Achieved, What Is to Be Expected
87
101
.